Description
Product details
RUDIX FDCM IV Ferric Carboxymaltose (50mg/10ml) Introduction RUDIX FDCM IV is an intravenous iron replacement therapy containing Ferric Carboxymaltose (50mg/10ml). This medication is specifically designed to treat iron deficiency anemia in patients who are unable to tolerate oral iron supplements or have not responded adequately to them. RUDIX FDCM IV offers a rapid and effective solution for replenishing iron stores and improving hemoglobin levels. Active Ingredient Ferric Carboxymaltose Ferric Carboxymaltose is a non-dextran iron complex used for intravenous iron supplementation. It consists of iron bound to a carbohydrate polymer, allowing for controlled and targeted delivery of iron to the body's iron stores. This formulation reduces the risk of free iron toxicity and enhances the safety profile of the medication. Uses RUDIX FDCM IV is indicated for: Iron Deficiency Anemia: Treatment of iron deficiency anemia in adults and adolescents aged 14 years and older. Intolerance to Oral Iron: Suitable for patients who cannot tolerate oral iron supplements due to gastrointestinal side effects. Insufficient Response to Oral Iron: Ideal for patients who have not achieved adequate improvement in hemoglobin levels with oral iron therapy. Dosage and Administration RUDIX FDCM IV is administered intravenously, typically in a clinical setting under the supervision of a healthcare professional. The dosage and frequency depend on the severity of the iron deficiency, the patient's body weight, and their hemoglobin levels. The infusion can be given as a single high-dose infusion or divided into multiple smaller doses. Side Effects Common side effects of RUDIX FDCM IV may include: Injection Site Reactions: Pain, swelling, or redness at the injection site. Nausea: Mild to moderate nausea may occur. Headache: Common but usually transient. Serious side effects, although rare, may include: Hypersensitivity Reactions: Such as rash, itching, or difficulty breathing. Immediate medical attention is required. Hypertension: Temporary increase in blood pressure post-infusion. Precautions Before receiving RUDIX FDCM IV, inform your healthcare provider if you have: Allergies: To Ferric Carboxymaltose or any other medications. Medical Conditions: Such as liver disease, infections, or a history of multiple drug allergies. Pregnancy or Breastfeeding: Use under the guidance of a healthcare provider to weigh potential risks and benefits. Drug Interactions RUDIX FDCM IV may interact with other medications. Inform your healthcare provider about all the medications you are currently taking, including: Other Iron Supplements: To avoid iron overload. Oral Iron Therapy: Concurrent use with oral iron supplements is typically not recommended. ACE Inhibitors: As they may increase the risk of side effects. Conclusion RUDIX FDCM IV, containing Ferric Carboxymaltose, is a highly effective intravenous iron replacement therapy for treating iron deficiency anemia. It offers a rapid and well-tolerated solution for patients who cannot take oral iron or have not responded to it. Administered under medical supervision, RUDIX FDCM IV ensures safe and efficient replenishment of iron stores, leading to improved hemoglobin levels and overall health. Always consult with your healthcare provider to ensure RUDIX FDCM IV is the appropriate treatment for your condition and to understand the potential risks and benefits associated with its use. For further information: Email: info@sterispharma.com / contact@sterispharma.com Call/WhatsApp: 7877551268, 7849827488 Buy Now:
